Act Two Investors’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-526
Closed -$269K 40
2025
Q1
$269K Sell
526
-50,495
-99% -$24.1M 0.06% 39
2024
Q4
$23.9M Sell
51,021
-638
-1% -$321K 4.66% 8
2024
Q3
$27.3M Sell
51,659
-1,660
-3% -$813K 5.15% 8
2024
Q2
$23.2M Buy
53,319
+1,663
+3% +$759K 4.6% 9
2024
Q1
$24.7M Buy
51,656
+462
+0.9% +$213K 4.97% 8
2023
Q4
$24M Buy
51,194
+1,168
+2% +$547K 5.18% 8
2023
Q3
$22M Buy
50,026
+3,293
+7% +$1.45M 5.89% 7
2023
Q2
$21.3M Buy
46,733
+7,109
+18% +$3.23M 5.96% 7
2023
Q1
$18.3M Buy
39,624
+30,203
+321% +$14M 7.29% 5
2022
Q4
$5.14M Sell
9,421
-1,009
-10% -$526K 5.31% 7
2022
Q3
$4.91M Sell
10,430
-1,344
-11% -$640K 4.96% 7
2022
Q2
$5.63M Sell
11,774
-1,478
-11% -$679K 5.31% 8
2022
Q1
$5.93M Buy
13,252
+783
+6% +$323K 4.7% 7
2021
Q4
$4.83M Sell
12,469
-54,826
-81% -$20.4M 3.8% 8
2021
Q3
$24.2M Buy
67,295
+57,825
+611% +$20.9M 5.75% 7
2021
Q2
$3.44M Buy
9,470
+4,470
+89% +$1.61M 0.67% 25
2021
Q1
$1.62M Buy
+5,000
New +$1.51M 0.36% 28

Other funds holding NOC

Act Two Investors's NOC Position: Q2 2025 in Review

Act Two Investors sold out of Northrop Grumman (NOC) in Q2 2025, closing a stake of 526 shares — an estimated $269K sold.

Act Two Investors first reported a position in NOC in Q1 2021 and held it in 17 quarters. The position peaked at $27.3M in Q3 2024. 1,616 funds tracked by Wall St. Rank hold NOC as of Q2 2025.

  • Act Two Investors reported no remaining Northrop Grumman position as of Q2 2025 after selling out during the quarter.
  • Act Two Investors sold 526 Northrop Grumman shares in Q2 2025, an estimated $269K.
  • Act Two Investors first reported a position in Northrop Grumman in Q1 2021 and held it in 17 quarters.
  • Act Two Investors's Northrop Grumman position peaked at $27.3M in Q3 2024.
  • 1,616 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2025.

Based on Act Two Investors's 13F filing for Q2 2025, filed 12 Aug 2025.